The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Genomic profiling of non-small cell lung cancer (NSCLC) for personalized targeted therapy using CT-guided transthoracic needle biopsy (TTNB).
Ritu R. Gill
No relevant relationships to disclose
Stephanie Heon
No relevant relationships to disclose
Beow Yong Yeap
No relevant relationships to disclose
Mohit Butaney
No relevant relationships to disclose
Neal Ian Lindeman
No relevant relationships to disclose
Michael S. Rabin
Consultant or Advisory Role - Genentech
David Michael Jackman
Consultant or Advisory Role - Foundation Medicine (U); Genentech (U)
Pasi Antero Janne
Consultant or Advisory Role - Abbott Laboratories; Boehringer Ingelheim; FORMA Therapeutics; Genentech; Pfizer (U); Quintiles; Roche
Other Remuneration - LabCorp
Bruce E. Johnson
Consultant or Advisory Role - Acceleron Pharma; AstraZeneca; Celgene; Chugai Pharma; Genentech; Genzyme; Millennium; Pfizer